Octave Bioscience

About Octave Bioscience

Octave Bioscience is focused on unlocking insights in multiple sclerosis (MS) care through precision neurology. Their mission is to provide data-driven, clinically relevant insights via accessible blood tests to empower patients and providers in making informed care decisions, transforming the future of precision medicine for neurodegenerative diseases.

Products & Services

Octave MSDA Test:The first and only multi-analyte biomarker blood test specifically developed to measure MS disease activity, offering detailed, personalized reporting for patients and providers.

Specialties

Precision Neurology Multiple Sclerosis (MS) Care Biomarker Blood Testing Neurodegenerative Diseases

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 35600000 MR: - FA: $35.6 million FAN: 35600000	D: 2025-09-04 FD: 2025-09-04	10 investors
2	RT: Grant T: - FT: Grant	A: 10000000 MR: - FA: $10 Million FAN: 10000000	D: 2023-11-15 FD: 2023-11-15	1 investors
3	RT: Series B Extension T: - FT: Series B Extension	A: 30000000 MR: - FA: $30M FAN: 30000000	D: 2023-07-26 FD: 2023-07-26	10 investors

Series C Latest

2025-09-04

$35.6M

10 investors (Pro only)

Grant 2023-11-15

$10.0M

Series B Extension 2023-07-26

$30.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

Doug Biehn

President, Chief Executive Officer

LinkedIn (Pro only)

M

Marcel Konrad

Chief Financial Officer

LinkedIn (Pro only)

J

Jeron Evans

Chief Revenue Officer

LinkedIn (Pro only)

D

Debbie Ledet

Chief Access Officer

F

Ferhan Qureshi

Senior Vice President, Biomarker R&D

T

Terrie Livingston

Vice President, Medical Affairs

View 15 more team members with Pro

Unlock Full Team Directory

Recent News